Biohaven Pharmaceutical Holding Co Ltd (BHVN) Insider Trading
- $50,193,670.33
- $174,604,264.32
- Oct. 2, 2024
- Gregory Bailey
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Feb. 1, 2018 | VP | 5,000 | $32.78 | Sell | $163,900.00 | |
| Jan. 31, 2018 | Director | 50,000 | $33.71 | Sell | $1,685,500.00 | |
| Jan. 22, 2018 | CFO | 10,000 | $32.50 | Sell | $325,000.00 | |
| Jan. 22, 2018 | Director | 49,000 | $30.76 | Sell | $1,507,240.00 | |
| Jan. 19, 2018 | Major Shareholder | 35,119 | $30.03 | Sell | $1,054,623.57 | |
| Jan. 18, 2018 | Director | 128,058 | $26.95 | Sell | $3,451,163.10 | |
| Jan. 16, 2018 | Director | 40,000 | $26.52 | Sell | $1,060,800.00 | |
| Jan. 12, 2018 | Director | 121,942 | $26.78 | Sell | $3,265,606.76 | |
| Jan. 10, 2018 | Director | 40,362 | $27.69 | Sell | $1,117,623.78 | |
| Jan. 10, 2018 | Insider | 35,000 | $27.52 | Sell | $963,200.00 | |
| Jan. 9, 2018 | Major Shareholder | 84,881 | $30.06 | Sell | $2,551,522.86 | |
| Jan. 5, 2018 | Major Shareholder | 22,996 | $30.03 | Sell | $690,569.88 | |
| Jan. 4, 2018 | Director | 50,000 | $28.71 | Sell | $1,435,500.00 | |
| Jan. 3, 2018 | Major Shareholder | 35,650 | $28.61 | Sell | $1,019,946.50 | |
| Jan. 2, 2018 | VP | 5,000 | $27.60 | Sell | $138,000.00 | |
| Dec. 20, 2017 | Director | 39,430 | $26.31 | Sell | $1,037,403.30 | |
| Dec. 19, 2017 | Insider | 10,000 | $24.10 | Sell | $241,000.00 | |
| Dec. 11, 2017 | Insider | 25,000 | $21.28 | Sell | $532,000.00 | |
| Dec. 1, 2017 | VP | 5,000 | $21.99 | Sell | $109,950.00 | |
| Nov. 30, 2017 | Director | 9,970 | $25.48 | Sell | $254,035.60 | |
| Nov. 27, 2017 | Director | 20,600 | $25.92 | Sell | $533,952.00 | |
| Nov. 24, 2017 | Director | 600 | $26.02 | Sell | $15,612.00 | |
| Nov. 14, 2017 | Insider | 160,000 | $25.76 | Sell | $4,121,600.00 | |
| Nov. 10, 2017 | CFO | 30,538 | $26.58 | Sell | $811,700.04 | |
| Nov. 9, 2017 | Insider | 27,423 | $26.60 | Sell | $729,451.80 | |
| Nov. 1, 2017 | VP | 5,000 | $29.28 | Sell | $146,400.00 | |
| Nov. 1, 2017 | Insider | 30,000 | $29.25 | Sell | $877,500.00 | |
| Nov. 1, 2017 | CEO | 150,000 | $29.41 | Sell | $4,411,500.00 | |
| May 9, 2017 | Insider | 50 | $17.00 | Buy | $850.00 | |
| May 9, 2017 | Director | 470,000 | $17.00 | Buy | $7,990,000.00 | |
| May 9, 2017 | CFO | 2,500 | $17.00 | Buy | $42,500.00 |
Insiders are both buying and selling Biohaven Pharmaceutical Holding Co Ltd stock.
The insider traders at Biohaven Pharmaceutical Holding Co Ltd are: Gregory Bailey, Declan Doogan, Robert Berman, John W Childs, Vlad Coric, Kimberly Gentile, James Engelhart, Eric Aguiar, Portage Biotech Inc., John Tilton, Elyse Stock, George C Clark, Julia P Gregory, Matthew Buten, William A Jones Jr, Irina Antonijevic, John W. Childs, and Albert Cha
The most active insider trader at Biohaven Pharmaceutical Holding Co Ltd is Gregory Bailey with 23 trades.
Declan Doogan has sold the most Biohaven Pharmaceutical Holding Co Ltd stock with a total value of $54,363,862.56.
Vlad Coric has bought the most Biohaven Pharmaceutical Holding Co Ltd stock with a total value of $22,697,111.10.
The most recent insider trade for Biohaven Pharmaceutical Holding Co Ltd was on Oct. 2, 2024.
The single biggest insider buy for Biohaven Pharmaceutical Holding Co Ltd was from Vlad Coric with a total value of $8,960,490.00 on Oct. 25, 2022.
The single biggest insider sell for Biohaven Pharmaceutical Holding Co Ltd was from Gregory Bailey with a total value of $11,682,287.82 on June 19, 2020.